Research Grants 11 show all


$750K
2009

$177.6K
2010

$820.9K
2015

$868.5K
2016

$199.9K
2018

Patents 24show all

  • 11
    C12N - Microorganisms or enzymes
  • 10
    C07K - Peptides
  • 5
    A61K - Preparations for medical, dental, or toilet purposes
  • 5
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 4
    A01K - Animal husbandry
  • 4
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 1
    C12Y - Enzymes

SEC Filings show all


8
D

Contact Information

Cambridge, MA
United States

SEC Form D Funding Events

DateOfferedSoldType
2015-03-09$1,500,000$338,191Equity, Debt, Option to Acquire
2013-06-05$800,000$502,000Equity, Option to Acquire
2012-08-28$5,000,000$2,474,231Equity
2009-12-07$490,308$490,308Equity, Option to Acquire
2007-08-08Unknown Unknown Other (Paper Filing)

Key Executives

  • William E Gordon
    Executive Officer, Director
  • Theodore Clark
    Executive Officer, Director
  • R. Douglas Kahn
    Director
  • Christopher Taron
    Director
  • Martin Gorovsky
    Director
  • Marc Franzman
    Executive Officer
  • John Reilly
    Executive Officer
  • R. Douglass Kahn
    Director
  • Marco Cacciuttolo
    Executive Officer, Director
  • Ben Machielse
    Director
  • Robert Gailus
    Director
  • Kevin O'Brien
    Executive Officer